AMGA's response to an RFI from CMS on regulatory relief in Medicare stresses the never-ending need to focus on patient care instead of working to meet administrative compliance requirements.
Alexandria, Virginia — A full 2 weeks before HHS and CMS announced their intent to revamp the currently oft-despied prior authorization process, the American Medical Group Association addressed the issue, along with improving the documentation process, harmonizing quality measure reporting across CMS programs, and maintaining flexibilities for telehealth services in its response to CMS' Medicare Rrgulatory Relief request for information (RFI).
The RFI asked such questions as what changes can be made to simplify Medicare reporting and documentation requirements without affecting program integrity, are there documentation or reporting requirements within the Medicare program that are overly complex or redundant, and how can Medicare better align its requirements with best practices and industry standards without imposing additional regulatory requirements?
Jerry Penso, MD, MBA | Image Credit: AMGA
"Medicare’s regulatory framework is due for an update, and AMGA is pleased CMS is looking to modernize the system," said Jerry Penso, MD, MBA, AMGA president and CEO.
AMGA's response stressed the never-ending need to focus on patient care instead of working to meet administrative compliance requirements, and "ensuring regulations support rather than hinder the ability of multispecialty group practices and integrated systems of care to best meet the needs of their patients and community."
Read all about this report, and to see AMGA's complete response to CMS, click here.
AI in Health Care: Balancing Governance, Innovation, and Trust
September 2nd 2025In this conversation with Reuben Daniel, associate vice president of artificial intelligence at UPMC Health Plan, we dive into how UPMC Health Plan builds trust with providers and members, discuss challenges of scaling AI effectively, and hear about concrete examples of AI's positive impact.
Listen
Stagnation in Reimbursement Keeps Biomedical Innovation From Reaching All Patients, COA Panel Says
September 9th 2025Panelists at the Community Oncology Alliance Payer Exchange Summit discuss the urgent need for innovative reimbursement models in cancer care to match advancements in biomedical technology and drug discovery.
Read More